6 inhibitors for metastatic breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, March 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,887 followers.

RT @cancerrehabMD: Tailor diagnosis and treatment of #edema in #cancer. PI3K/mTor/CDK4/6 inhibitors can cause, mimic or exacerbate #lymphed…

17 Nov 2019

Reply Repost Favourite

Tailor diagnosis and treatment of #edema in #cancer. PI3K/mTor/CDK4/6 inhibitors can cause, mimic or exacerbate #lymphedema but do not have the same trajectory as traditional concept of BCRL #breastcancer https://t.co/SRwy8Pf0ZC

17 Nov 2019

Reply Repost Favourite

Best Study of the Day: Peripheral edema in patients receiving PI3K/mTOR/CDK4/6 targeted therapy for metastatic breast cancer https://t.co/fymj7AOnXG - Breast Cancer Research and Treatment - #breast #cancer #oncology #tumori #seno #mammella #oncologia #ed

05 Apr 2019

Reply Repost Favourite

Incidence of peripheral edema in patients receiving PI3K/mTOR/CDK4/6 inhibitors for metastatic breast cancer. Breast Cancer Res Treat #cancer #epidemiology https://t.co/OVDEYGCbxG

29 Mar 2019

Reply Repost Favourite